Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Sep;63(9):3396–3400. doi: 10.1128/iai.63.9.3396-3400.1995

Effect of hypertriglyceridemia on endotoxin responsiveness in humans.

T van der Poll 1, C C Braxton 1, S M Coyle 1, M A Boermeester 1, J C Wang 1, P M Jansen 1, W J Montegut 1, S E Calvano 1, C E Hack 1, S F Lowry 1
PMCID: PMC173467  PMID: 7642268

Abstract

Triglyceride-rich lipoproteins can inhibit endotoxin activity in vitro and in rodents. We sought to determine whether Intralipid, a triglyceride-rich fat emulsion which in contact with plasma functions similarly to endogenous lipoproteins, can alter the human response to endotoxin. Intralipid inhibited endotoxin-induced cytokine production in human whole blood in vitro in a dose-dependent manner, with maximal inhibition (up to 70%) being achieved at a concentration of 10 g/liter. In healthy men, a bolus intravenous injection of endotoxin (lot EC-5; 20 U/kg of body weight) was given midway through a 4-h infusion (125 ml/h) of either 5% glucose (n = 5) or 20% Intralipid (n = 5). The infusion of Intralipid led to an increase in triglyceride levels in serum from 95 +/- 16 to 818 +/- 135 mg/dl prior to endotoxin administration, i.e., levels that importantly reduced cytokine production in endotoxin-stimulated whole blood. However, in vivo hypertriglyceridemia did not influence inflammatory responses to endotoxin (fever, release of tumor necrosis factor and soluble tumor necrosis factor receptors, and leukocytosis) or even potentiated endotoxin responses (release of interleukins 6 and 8 and neutrophil degranulation). Hypertriglyceridemia does not inhibit the in vivo responses to endotoxin in humans.

Full Text

The Full Text of this article is available as a PDF (223.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOBERG J., CARLSON L. A. DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA. Clin Chim Acta. 1964 Nov;10:420–427. doi: 10.1016/0009-8981(64)90171-8. [DOI] [PubMed] [Google Scholar]
  2. Cavaillon J. M., Fitting C., Haeffner-Cavaillon N., Kirsch S. J., Warren H. S. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun. 1990 Jul;58(7):2375–2382. doi: 10.1128/iai.58.7.2375-2382.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DeForge L. E., Kenney J. S., Jones M. L., Warren J. S., Remick D. G. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J Immunol. 1992 Apr 1;148(7):2133–2141. [PubMed] [Google Scholar]
  4. Donnelly T. M., Kelsey S. F., Levine D. M., Parker T. S. Control of variance in experimental studies of hyperlipidemia using the WHHL rabbit. J Lipid Res. 1991 Jul;32(7):1089–1098. [PubMed] [Google Scholar]
  5. Eichbaum E. B., Harris H. W., Kane J. P., Rapp J. H. Chylomicrons can inhibit endotoxin activity in vitro. J Surg Res. 1991 Nov;51(5):413–416. doi: 10.1016/0022-4804(91)90143-a. [DOI] [PubMed] [Google Scholar]
  6. Emancipator K., Csako G., Elin R. J. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun. 1992 Feb;60(2):596–601. doi: 10.1128/iai.60.2.596-601.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Erkelens D. W., Brunzell J. D., Bierman E. L. Availability of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man. Metabolism. 1979 May;28(5):495–501. doi: 10.1016/0026-0495(79)90188-4. [DOI] [PubMed] [Google Scholar]
  8. Feingold K. R., Staprans I., Memon R. A., Moser A. H., Shigenaga J. K., Doerrler W., Dinarello C. A., Grunfeld C. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res. 1992 Dec;33(12):1765–1776. [PubMed] [Google Scholar]
  9. Flegel W. A., Baumstark M. W., Weinstock C., Berg A., Northoff H. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun. 1993 Dec;61(12):5140–5146. doi: 10.1128/iai.61.12.5140-5146.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Flegel W. A., Wölpl A., Männel D. N., Northoff H. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun. 1989 Jul;57(7):2237–2245. doi: 10.1128/iai.57.7.2237-2245.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gallin J. I., Kaye D., O'Leary W. M. Serum lipids in infection. N Engl J Med. 1969 Nov 13;281(20):1081–1086. doi: 10.1056/NEJM196911132812001. [DOI] [PubMed] [Google Scholar]
  12. Glauser M. P., Zanetti G., Baumgartner J. D., Cohen J. Septic shock: pathogenesis. Lancet. 1991 Sep 21;338(8769):732–736. doi: 10.1016/0140-6736(91)91452-z. [DOI] [PubMed] [Google Scholar]
  13. Granot E., Deckelbaum R. J., Eisenberg S., Oschry Y., Bengtsson-Olivecrona G. Core modification of human low-density lipoprotein by artificial triacylglycerol emulsion. Biochim Biophys Acta. 1985 Feb 8;833(2):308–315. doi: 10.1016/0005-2760(85)90203-6. [DOI] [PubMed] [Google Scholar]
  14. HALLBERG D. STUDIES ON THE ELIMINATION OF EXOGENOUS LIPIDS FROM THE BLOOD STREAM. DETERMINATION AND SEPARATION OF THE PLASMA TRIGLYCERIDES AFTER SINGLE INJECTION OF A FAT EMULSION IN MAN. Acta Physiol Scand. 1964 Dec;62:407–421. doi: 10.1111/j.1748-1716.1964.tb10438.x. [DOI] [PubMed] [Google Scholar]
  15. HALLBERG D., WERSAELL J. THE ELECTRON-MICROSCOPIC INVESTIGATION OF CHYLOMICRONS AND FAT EMULSIONS FOR INTRAVENOUS USE. Acta Chir Scand Suppl. 1964;325:SUPPL 325–325:25. [PubMed] [Google Scholar]
  16. Hack C. E., Hart M., van Schijndel R. J., Eerenberg A. J., Nuijens J. H., Thijs L. G., Aarden L. A. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun. 1992 Jul;60(7):2835–2842. doi: 10.1128/iai.60.7.2835-2842.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hansen L. M., Hardie B. S., Hidalgo J. Fat emulsion for intravenous administration: clinical experience with intralipid 10%. Ann Surg. 1976 Jul;184(1):80–88. doi: 10.1097/00000658-197607000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Harris H. W., Grunfeld C., Feingold K. R., Rapp J. H. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest. 1990 Sep;86(3):696–702. doi: 10.1172/JCI114765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Harris H. W., Grunfeld C., Feingold K. R., Read T. E., Kane J. P., Jones A. L., Eichbaum E. B., Bland G. F., Rapp J. H. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest. 1993 Mar;91(3):1028–1034. doi: 10.1172/JCI116259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Helle M., Boeije L., de Groot E., de Vos A., Aarden L. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods. 1991 Apr 8;138(1):47–56. doi: 10.1016/0022-1759(91)90063-l. [DOI] [PubMed] [Google Scholar]
  21. Hoffman W. D., Natanson C. Endotoxin in septic shock. Anesth Analg. 1993 Sep;77(3):613–624. doi: 10.1213/00000539-199309000-00032. [DOI] [PubMed] [Google Scholar]
  22. Jarstrand C., Rasool O. Intralipid decreases the bacterial lipopolysaccharide induced release of oxygen radicals and lysozyme from human neutrophils. Scand J Infect Dis. 1991;23(4):481–487. doi: 10.3109/00365549109075097. [DOI] [PubMed] [Google Scholar]
  23. Kenney J. S., Masada M. P., Eugui E. M., Delustro B. M., Mulkins M. A., Allison A. C. Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity. J Immunol. 1987 Jun 15;138(12):4236–4242. [PubMed] [Google Scholar]
  24. Leeuwenberg J. F., Jeunhomme T. M., Buurman W. A. Slow release of soluble TNF receptors by monocytes in vitro. J Immunol. 1994 Apr 15;152(8):4036–4043. [PubMed] [Google Scholar]
  25. Liao W., Florén C. H. Hyperlipidemic response to endotoxin--a part of the host-defence mechanism. Scand J Infect Dis. 1993;25(6):675–682. doi: 10.3109/00365549309008562. [DOI] [PubMed] [Google Scholar]
  26. Martich G. D., Boujoukos A. J., Suffredini A. F. Response of man to endotoxin. Immunobiology. 1993 Apr;187(3-5):403–416. doi: 10.1016/S0171-2985(11)80353-0. [DOI] [PubMed] [Google Scholar]
  27. Nuijens J. H., Abbink J. J., Wachtfogel Y. T., Colman R. W., Eerenberg A. J., Dors D., Kamp A. J., Strack van Schijndel R. J., Thijs L. G., Hack C. E. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med. 1992 Feb;119(2):159–168. [PubMed] [Google Scholar]
  28. Read T. E., Grunfeld C., Kumwenda Z., Calhoun M. C., Kane J. P., Feingold K. R., Rapp J. H. Triglyceride-rich lipoproteins improve survival when given after endotoxin in rats. Surgery. 1995 Jan;117(1):62–67. doi: 10.1016/s0039-6060(05)80231-4. [DOI] [PubMed] [Google Scholar]
  29. Robinson S. F., Quarfordt S. H. Apoproteins in association with Intralipid incubations in rat and human plasma. Lipids. 1979 Apr;14(4):343–349. doi: 10.1007/BF02533417. [DOI] [PubMed] [Google Scholar]
  30. Ulevitch R. J., Johnston A. R., Weinstein D. B. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J Clin Invest. 1979 Nov;64(5):1516–1524. doi: 10.1172/JCI109610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Vilaró S., Llobera M. Uptake and metabolism of Intralipid by rat liver: an electron-microscopic study. J Nutr. 1988 Aug;118(8):932–940. doi: 10.1093/jn/118.8.932. [DOI] [PubMed] [Google Scholar]
  32. van der Poll T., Jansen J., Endert E., Sauerwein H. P., van Deventer S. J. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun. 1994 May;62(5):2046–2050. doi: 10.1128/iai.62.5.2046-2050.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES